The FDA has approved the first blood test for Alzheimer's, allowing for earlier diagnosis and treatment with existing drugs. This groundbreaking development could significantly impact millions facing cognitive decline.
The FDA has approved the first blood test for Alzheimer's, allowing for earlier treatment with existing drugs. This innovative test measures protein ratios linked to the disease, promising better patient outcomes.
Billy Evans, partner of Theranos founder Elizabeth Holmes, is launching a new blood-testing venture called Haemanthus, raising eyebrows and questions about repeating past mistakes in health technology.
Billy Evans, partner of Theranos founder Elizabeth Holmes, is raising millions for Haemanthus, a new blood-testing company with striking similarities to its infamous predecessor. Can he succeed where Holmes failed?
A groundbreaking blood test developed by researchers may change how Alzheimer's is diagnosed and treated, providing insights into the disease's progression and helping identify suitable medications.
